About Nuo Therapeutics
Nuo Therapeutics, Inc., formerly Cytomedix, Inc., is a regenerative therapies company developing and marketing products within the United States and internationally through its strategic partners. The Company commercializes cell-based technologies that harness the regenerative capacity of the human body to trigger natural healing. The Company's commercial offerings are centered on its point of care platform technologies for the separation of blood and bone marrow to produce platelet based therapies or cell concentrates. It is promoting two distinct platelet rich plasma (PRP) technologies: the Aurix System for wound care, and the Angel concentrated Platelet Rich Plasma (cPRP) System for orthopedics and cardiovascular markets. The Company is focused on developing product candidates utilizing the Bright Cell technology platform, owned by its subsidiary, Aldagen, Inc.
Industry, Sector and Symbol:
- Sector: N/A
- Industry: N/A
- Sub-Industry: N/A
- Exchange: OTCMKTS
- Symbol: CMXI
- Previous Close: $0.00
- 50 Day Moving Average: $
- 200 Day Moving Average: $
- Trailing P/E Ratio:
- P/E Growth:
- Market Cap: $
Consensus Ratings for Nuo Therapeutics (OTCMKTS:CMXI) (?) The ratings breakdown includes the most recent rating from each analyst that has rated the stock within the last twelve months. The ratings score is a calculation of the average number of sell, hold, buy and strong buy ratings (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). The consensus price target is a mean average of the most recent price target set by each analyst that has set a price target for the stock in the last twelve months.
|Ratings Breakdown: ||No ratings tracked in the last 12 months.|
|Consensus Rating:||N/A (Score: NaN)|
|Consensus Price Target: ||N/A|
Analysts' Ratings History for Nuo Therapeutics (OTCMKTS:CMXI)
No equities research coverage for this company has been tracked by MarketBeat.com
Earnings History for Nuo Therapeutics (OTCMKTS:CMXI)
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
Earnings Estimates for Nuo Therapeutics (OTCMKTS:CMXI)
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for Nuo Therapeutics (OTCMKTS:CMXI)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for Nuo Therapeutics (OTCMKTS:CMXI)
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
|10/6/2014||Dean Tozer||Insider||Buy||33,300||$0.36||$11,988.00|| |
|9/12/2014||Dean Tozer||Insider||Buy||40,000||$0.45||$18,000.00|| |
|8/29/2014||Dean Tozer||Insider||Buy||40,000||$0.35||$14,000.00|| |
|8/26/2014||Steven A Shallcross||CFO||Buy||27,500||$0.38||$10,450.00|| |
|8/22/2014||Dean Tozer||Insider||Buy||38,700||$0.38||$14,706.00|| |
|8/20/2014||Dean Tozer||Insider||Buy||48,000||$0.39||$18,720.00|| |
|8/20/2014||Martin P Rosendale||CEO||Buy||25,000||$0.40||$10,000.00|| |
|8/20/2014||Steven A Shallcross||CFO||Buy||52,000||$0.39||$20,280.00|| |
|5/21/2013||David Emerson Jorden||Director||Buy||80,000||$0.50||$40,000.00|| |
|4/19/2013||David Emerson Jorden||Director||Buy||50,000||$0.51||$25,500.00|| |
|4/9/2013||David Emerson Jorden||Director||Buy||75,000||$0.51||$38,250.00|| |
|4/4/2013||Martin P Rosendale||CEO||Buy||17,231||$0.52||$8,960.12|| |
|2/27/2013||David Emerson Jorden||Director||Buy||25,000||$0.52||$13,000.00|| |
|2/22/2013||Aldagen Holdings, Llc||Insider||Buy||281,819||$0.55||$155,000.45|| |
|2/22/2013||David Emerson Jorden||Director||Buy||50,000||$0.53||$26,500.00|| |
|2/22/2013||Martin P Rosendale||CEO||Buy||20,000||$0.53||$10,600.00|| |
|2/19/2013||Guercio Joseph Del||Director||Buy||509,091||$0.55||$280,000.05|| |
|9/14/2012||David Emerson Jorden||Director||Buy||25,000||$0.89||$22,250.00|| |
|9/11/2012||David Emerson Jorden||Director||Buy||8,333||$0.95||$7,916.35|| |
Headlines for Nuo Therapeutics (OTCMKTS:CMXI)
No headlines for this company have been tracked by MarketBeat.com
What is Nuo Therapeutics' stock symbol?
Nuo Therapeutics trades on the OTCMKTS under the ticker symbol "CMXI."
How do I buy Nuo Therapeutics stock?
Shares of Nuo Therapeutics can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How much does a share of Nuo Therapeutics stock cost?
One share of Nuo Therapeutics stock can currently be purchased for approximately $0.34.
Nuo Therapeutics (OTCMKTS:CMXI) Chart for Monday, February, 20, 2017
Institutional Ownership ChartEarnings History ChartDividend History Chart